Literature DB >> 19688784

Activity-based probes for monitoring postproline protease activity.

Eduard Sabidó1, Teresa Tarragó, Sherry Niessen, Benjamin F Cravatt, Ernest Giralt.   

Abstract

Postproline proteases constitute a subset of serine proteases involved in the regulation of many signaling events and are emerging as promising therapeutic targets for prevalent diseases, such as diabetes and cancer. Therefore, monitoring their activity in different tissues and diverse physiological states would certainly facilitate the elucidation of their physiological role and the establishment of new therapeutic targets. Here, we have synthesized a dipeptidyl phosphonate activity-based probe that has proved to be highly selective for a specific postproline protease, prolyl oligopeptidase (POP). Its high sensitivity allows the detection of the endogenous activity of POP both by in-gel analysis and mass spectrometry. The evidence provided by mass spectrometry for the high selectivity of the synthesized probe opens the possibility of using dipeptidyl phosphonates not only for activity-based profiling (ABP), but also for other ABP applications like substrate-based protease identification.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19688784      PMCID: PMC2847404          DOI: 10.1002/cbic.200900244

Source DB:  PubMed          Journal:  Chembiochem        ISSN: 1439-4227            Impact factor:   3.164


  34 in total

1.  Effect of a novel prolyl endopeptidase inhibitor, JTP-4819, on neuropeptide metabolism in the rat brain.

Authors:  K Toide; T Fujiwara; Y Iwamoto; M Shinoda; K Okamiya; T Kato
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1996-02       Impact factor: 3.000

Review 2.  Prolyl cis-trans isomerization as a molecular timer.

Authors:  Kun Ping Lu; Greg Finn; Tae Ho Lee; Linda K Nicholson
Journal:  Nat Chem Biol       Date:  2007-10       Impact factor: 15.040

Review 3.  Proline-rich, amphipathic cell-penetrating peptides.

Authors:  Sílvia Pujals; Ernest Giralt
Journal:  Adv Drug Deliv Rev       Date:  2007-11-17       Impact factor: 15.470

Review 4.  The importance of proline residues in the structure, stability and susceptibility to proteolytic degradation of collagens.

Authors:  Stephen M Krane
Journal:  Amino Acids       Date:  2008-04-23       Impact factor: 3.520

5.  Dipeptide phosphonates as inhibitors of dipeptidyl peptidase IV.

Authors:  B Boduszek; J Oleksyszyn; C M Kam; J Selzler; R E Smith; J C Powers
Journal:  J Med Chem       Date:  1994-11-11       Impact factor: 7.446

6.  Enzyme activity profiles of the secreted and membrane proteome that depict cancer cell invasiveness.

Authors:  Nadim Jessani; Yongsheng Liu; Mark Humphrey; Benjamin F Cravatt
Journal:  Proc Natl Acad Sci U S A       Date:  2002-07-29       Impact factor: 11.205

7.  Modulation of inositol 1,4,5-triphosphate concentration by prolyl endopeptidase inhibition.

Authors:  Ingo Schulz; Bernd Gerhartz; Antje Neubauer; Andreas Holloschi; Ulrich Heiser; Mathias Hafner; Hans-Ulrich Demuth
Journal:  Eur J Biochem       Date:  2002-12

8.  Activation of the endocannabinoid system by organophosphorus nerve agents.

Authors:  Daniel K Nomura; Jacqueline L Blankman; Gabriel M Simon; Kazutoshi Fujioka; Roger S Issa; Anna M Ward; Benjamin F Cravatt; John E Casida
Journal:  Nat Chem Biol       Date:  2008-04-27       Impact factor: 15.040

9.  Influence of proline on the thermostability of the active site and membrane arrangement of transmembrane proteins.

Authors:  Alex Perálvarez-Marín; Victor A Lórenz-Fonfría; Rosana Simón-Vázquez; Maria Gomariz; Inmaculada Meseguer; Enric Querol; Esteve Padrós
Journal:  Biophys J       Date:  2008-07-25       Impact factor: 4.033

Review 10.  Proline-rich polypeptides in Alzheimer's disease and neurodegenerative disorders -- therapeutic potential or a mirage?

Authors:  A Gladkevich; F Bosker; J Korf; K Yenkoyan; H Vahradyan; M Aghajanov
Journal:  Prog Neuropsychopharmacol Biol Psychiatry       Date:  2007-06-21       Impact factor: 5.067

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.